Together we make things happen

Close up picture of nano particles

​Vironova revolutionizes access to transmission electron microscopy–based image analysis in biopharmaceutical development. Our solution enables automated analyses for faster and better-informed decisions to secure robust bioprocessing and final product quality.

Mohammed Homman

CEO, Vironova
 It has been an amazing experience to participate in Mohammed Homman’s journey developing Vironova, today an innovation leader in the industry of nanoparticle analysis.
– Peter Almberg 

CEO

  • Mohammed Homman

Katalysen Partner